AustinPx's formulation development expertise is grounded in our understanding of chemistry, preformulation and pharmaceutical development. Every company and molecule are unique and at AustinPx, we partner with our clients to understand their challenges and goals, then design a tailored project plan. Our goal is to provide formulation strategies that meet the specific physiochemical characteristics of the molecule, its intended use, and the needs of each client. Our technology approach is data-driven and unbiased. For poorly soluble molecules, we have one of the most powerful tools available in our next generation amorphous dispersion platform, KinetiSol® Technology.
We pride ourselves on our client-centric, service model, that ensures customized project plans, fast project initiation, solid science, and on-time delivery. From formulations for toxicology studies and first-in-human dosing, to scale up and tech transfer, our experts will deliver the results to help advance your drug candidate to the next phase.
Our experience includes first-in-human strategies, solutions for poorly soluble compounds, controlled release and handling of highly potent compounds. AustinPx’s formulation technologies and capabilities include:
- Molecule Characterization & Preformulation Testing
- Data-driven Technology Screening
- Formulations for GLP studies
Oral Drug Development
- Drug Product Intermediate and Finished Dose Development
- Solutions, Suspensions, Tablets and Capsules
- Bioavailability Enhancement Technologies
- Immediate and Modified Release
- Preclinical through Final Commercialized Product
Speed to Clinic and Market Approaches
- Phase Appropriate
- Accelerated Approval Programs
Our Pharmaceutics team is comprised of seasoned formulation scientists that will provide phase-appropriate guidance and development expertise.
Let our experts deliver the results you need to help advance your drug candidate to the next phase. Contact us about our Formulation Development services.